Last week, IDL Diagnostics participated as an exhibitor at WHX Labs Dubai together with concile as part of the recently announced joint venture. The main focus is on delivering multiple biomarkers across different POC reader configurations and supporting infection, cardiac, oncology, hormones and chronic disease testing in a structured, platform-driven way.
Visit from Beckman Coulter Diagnostics focused on market development
We had the pleasure of welcoming our long-term partner Beckman Coulter Diagnostics this week for valuable discussions on the continued sales and market development for our IRMA and ELISA portfolio. Their strong market presence and ability to effectively navigate a...
